| Harnessing the natural healing power of colostrum: bovine milk‐derived extracellular vesicles from colostrum facilitating the transition from inflammation to tissue … H Kim, DE Kim, G Han, NR Lim, EH Kim, Y Jang, H Cho, H Jang, KH Kim, ... Advanced Healthcare Materials 11 (6), 2102027, 2022 | 43 | 2022 |
| Potential of colostrum-derived exosomes for promoting hair regeneration through the transition from telogen to anagen phase H Kim, Y Jang, EH Kim, H Jang, H Cho, G Han, HK Song, SH Kim, Y Yang Frontiers in Cell and Developmental Biology 10, 815205, 2022 | 40 | 2022 |
| Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress G Han, H Cho, H Kim, Y Jang, H Jang, ES Kim, EH Kim, KY Hwang, K Kim, ... Biomaterials Science 10 (8), 2076-2087, 2022 | 40 | 2022 |
| The potential of bovine colostrum-derived exosomes to repair aged and damaged skin cells G Han, H Kim, DE Kim, Y Ahn, J Kim, YJ Jang, K Kim, Y Yang, SH Kim Pharmaceutics 14 (2), 307, 2022 | 36 | 2022 |
| Extracellular vesicles as potential therapeutics for inflammatory diseases HS Hwang, H Kim, G Han, JW Lee, K Kim, IC Kwon, Y Yang, SH Kim International journal of molecular sciences 22 (11), 5487, 2021 | 28 | 2021 |
| Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis H Kim, JH Back, G Han, SJ Lee, YE Park, MB Gu, Y Yang, JE Lee, SH Kim Biomaterials 286, 121578, 2022 | 27 | 2022 |
| A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA G Kwak, H Kim, J Park, EH Kim, H Jang, G Han, SY Wang, Y Yang, ... ACS nano 15 (7), 11369-11384, 2021 | 26 | 2021 |
| Advances in mRNA therapeutics for cancer immunotherapy: from modification to delivery G Han, D Noh, H Lee, S Lee, S Kim, HY Yoon, SH Lee Advanced Drug Delivery Reviews, 114973, 2023 | 24 | 2023 |
| Oral TNF-α siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease G Han, H Kim, H Jang, ES Kim, SH Kim, Y Yang Bioactive Materials 34, 138-149, 2024 | 19 | 2024 |
| Extracellular vesicles as potential theranostic platforms for skin diseases and aging H Kim, JW Lee, G Han, K Kim, Y Yang, SH Kim Pharmaceutics 13 (5), 760, 2021 | 16 | 2021 |
| Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery H Jang, H Kim, EH Kim, G Han, Y Jang, Y Kim, JW Lee, SC Shin, EEK Kim, ... Biomaterials Research 27 (1), 124, 2023 | 12 | 2023 |
| Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease B Park, G Han, DY Jin, KC Gil, D Shin, J Lee, JY Park, H Jang, D Park, ... ACS nano, 2024 | 1 | 2024 |
| The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System. Pharmaceutics 2023, 15, 21 T Li, X Li, G Han, M Liang, Z Yang, C Zhang, S Huang, S Tai, S Yu | 1 | 2022 |
| Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs H Jang, J Choi, D Park, G Han, EH Kim, K Kim, SH Kim, MK Shim, Y Yang Theranostics 14 (14), 5413, 2024 | | 2024 |
